Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloset add-on to GLP-1 analogs in T2DM
NCT02299050Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Jun 2014
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bromocriptine in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Jun 2014; status: completed.
02
Drugs
bromocriptine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02299050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299050.